The involvement of PARP-1 in controlling epigenetic modifications and chromatin architecture in a context-dependent manner makes PARylation an important player in the epigenetic control of transcriptional activity of genes potentially implicated in the pathogenesis of AD. This evidence concerns the gene PARP1 and Alzheimer disease.